|
|
|
[1和II期高危患者比较]
I和II期高危NSCLC治疗比较
日期：2020-02-28 22:05:24
点击：194
好评：2
RF Ablation Results: Comparative Therapies High-risk stage 1 and 2 NSCLC Modality 1-year 2-year 3-year 5-year LC DM Zemlyaketal SLR(25) 87.1% 12% 12% 3-ycancer-specific 90.6%,87.5%,90.2% 3-ycancer-free(p0.05) 60.8%,50%,45.6% RFA(12) 87.5%...
RF Ablation Results: Comparative Therapies High-risk stage 1 and 2 NSCLC Modalit...